CIK 0001393434
- Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $799,174
- in 9 filings, $788K under 10b5-1 plans
Net −$799,174. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Dugel Pravin −$233K Reporting owner sold <1% of stake
- Saroj Namrata −$232K Chief Business Officer sold 14% of stake
- Heier Jeffrey S. −$112K Chief Scientific Officer sold 4% of stake
- Kaiser Peter −$103K Chief Development Officer sold 5% of stake
- Anderman Todd −$87K Chief Legal Officer sold 8% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-01 | Warden Charles M Director | Grant or award · Stock Option (Right to Buy) | +13,500 | 13,500 | ||
| 2017-06-01 | PEACOCK BRUCE Director | Grant or award · Stock Option (Right to Buy) | +13,500 | 13,500 | ||
| 2017-06-01 | OSHEA WILLIAM J Director | Grant or award · Stock Option (Right to Buy) | +13,500 | 13,500 | ||
| 2017-06-01 | LINDSTROM RICHARD L MD Director | Grant or award · Stock Option (Right to Buy) | +13,500 | 13,500 | ||
| 2017-06-01 | Heier Jeffrey S. Director | Grant or award · Stock Option (Right to Buy) | +13,500 | 13,500 | ||
| 2017-01-31 | Talamo Jonathan H. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2017-01-31 | Ankerud Eric | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2017-01-31 | Hurley Charles Andrew Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2017-01-31 | Fortune James Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2017-01-31 | Sawhney Amarpreet President and CEO | Grant or award · Stock Option (Right to Buy) | +235,000 | 235,000 | ||
| 2017-01-31 | Smith W Bradford CFO and Treasurer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2016-12-15 | Sawhney Amarpreet President and CEO | Purchase | +45,300 | $7.85 | $356K | 677,390 |
| 2016-11-07 | Hurley Charles Andrew Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2016-08-05 | Sawhney Amarpreet President and CEO | Exercise or conversion | +58,357 | $1.35 | $79K | 632,090 |
| 2016-08-05 | Sawhney Amarpreet President and CEO | Exercise or conversion · Stock Option (Right to Buy) | −58,357 | 0 | ||
| 2016-07-25 | Talamo Jonathan H. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 | ||
| 2016-06-09 | Sawhney Amarpreet President and CEO | Purchase | +10,000 | $6.70 | $67K | 573,733 |
| 2016-06-02 | GARVEY JAMES M Director | Grant or award · Stock Option (Right to Buy) | +13,500 | 13,500 | ||
| 2016-06-02 | Warden Charles M Director | Grant or award · Stock Option (Right to Buy) | +13,500 | 13,500 | ||
| 2016-06-02 | Chadha Jaswinder Director | Grant or award · Stock Option (Right to Buy) | +13,500 | 13,500 |
Page 20 of 27 · 522 trades